Essential Partners’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
Essential Partners's DVAX Position: Q1 2026 in Review
Essential Partners sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 12 shares — an estimated $185 sold.
Essential Partners first reported a position in DVAX in Q4 2025 and held it in 1 quarter. The position peaked at $185 in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Essential Partners reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Essential Partners sold 12 Dynavax Technologies shares in Q1 2026, an estimated $185.
- Essential Partners first reported a position in Dynavax Technologies in Q4 2025 and held it in 1 quarter.
- Essential Partners's Dynavax Technologies position peaked at $185 in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.